Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: Long-term results of a monocentric series of 137 radically resected patients in a 5-year period

International Journal of Colorectal Disease

Volumn 28, Issue 2, 2013, Pages 207-215

  Biffi, Roberto ^a   Botteri, Edoardo ^a,b   Bertani, Emilio ^a   Zampino, Maria Giulia ^a   Cenciarelli, Sabina ^a   Luca, Fabrizio ^a   Pozzi, Simonetta ^a   Cossu, Maria Laura ^a   Chiappa, Antonio ^a   Rotmensz, Nicole ^a   Bazolli, Barbara ^a   Magni, Elena ^a   Sonzogni, Angelica ^a   Andreoni, Bruno ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Colon cancer; Lymphadenectomy; Radical colectomy; TNM stage

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLLOID CARCINOMA; COLON ADENOCARCINOMA; COLON RESECTION; DRUG INDICATION; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 85027950128     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-012-1563-y     Document Type: Article

References (32)

1. Greene FL, Page DL, Fleming ID et al (eds) (2002) AJCC Cancer Staging Handbook, 6th edn. Springer, New York
2. Greene FL, Stewart AK, Norton HJ (2002) A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 236:416-421
3. Greene FL, Stewart AK, Norton HJ (2004) New tumor-node-metastasis staging strategy for node positive (stage III) rectal cancer: an analysis. J Clin Oncol 22:1778-1784
4. Meyerhardt JA, Mayer RJ (2005) Systemic therapy for colorectal cancer. N Engl J Med 352:476-487
5. O'Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96:1420-1425
6. Gill S, Loprinzi CL, Sargent DJ et al (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22:1797-1806
7. Benson AB III, Schrag D, Somerfield MR et al (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408-3419
8. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 88:1739-1757
9. Cunningham D, Atkin W, Lenz HJ et al (2010) Colorectal cancer. Lancet 20(375):1030-1047
10. Botteri E, Iodice S, Maisonneuve P et al (2009) Case mix at the European Institute of Oncology: first report of the Tumour Registry, years 2000-2002. Ecancermedsci. doi: 10.3332/ecancer.2009.149
11. Krasna MJ, Flancbaum L, Cody RP et al (1988) Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 61:1018-1023
12. Wanebo HJ, Rao B, Pinsky CM et al (1978) Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299:448-451
13. Wolmark N, Fisher B, Wieand HS et al (1984) The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. Ann Surg 199:375-382
14. Moertel CG, Fleming TR, Macdonald JS et al (1995) Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol 13:2936-2943
15. Durrleman S, Simon R (1989) Flexible regression models with cubic splines. Stat Med 8:551-561
16. Mamounas E, Wieand S, Wolmark N et al (1999) Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17:1349-1355
17. Quasar Collaborative Group (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised trial. Lancet 370:2020-2029
18. Jonker DJ, Spithoff K, Maroun J, Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care (2011) Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline. Clin Oncol (R Coll Radiol) 23(5):314-322
19. Winn R, McClure J (2003) The NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 1:9
20. Andre T, Boni C, Navarro M et al (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as an adjuvant treatment in stage II and III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116
21. Goldstein NS (2002) Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26:179-189
22. Sarli L, Bader G, Iusco D et al (2005) Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 41:272-279
23. Swanson RS, Compton CC, Stewart AK, Bland KI (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10:65-71
24. Baxter NN, Virnig DJ, Rothenberger DA et al (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219-225
25. Bui L, Rempel E, Reeson D, Simunovic M (2006) Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol 93:439-445
26. Jestin P, Pahlman L, Glimelius B, Gunnarsson U (2005) Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer 41:2071-2078
27. Lemmens VE, Verheij CD, Janssen-Heijnen ML et al (2006) Mixed adherence to clinical practice guidelines for colorectal cancer in the Southern Netherlands in 2002. Eur J Surg Oncol 32:168-173
28. Maurel J, Launoy G, Grosclaude P et al (1998) Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer 82:1482-1486
29. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA (2007) Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 99:433-441
30. Carloss H, Huang B, Cohen A, Carloss E, Wyatt S, Tucker T (2004) The impact of number of lymph nodes removed on five-year survival in stage II colon and rectal cancer. J Ky Med Assoc 102:345-347
31. Wong JH, Bowles BJ, Bueno R, Shimizu D (2002) Impact of the number of negative nodes on disease-free survival in colorectal cancer patients. Dis Colon Rectum 45:1341-1348
32. Koebrugge B, Vogelaar FJ, Lips DJ, Pruijt JF, van der Linden JC, Ernst MF, Bosscha K (2011) The number of high-risk factors is related to outcome in stage II colonic cancer patients. Eur J Surg Oncol 37(11):964-970